company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3501000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3501000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,235000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,98000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-695000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3828000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3828000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16699000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3850000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12888000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12888000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-44000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-25000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-25000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16741000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4052000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4052000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,39000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,229000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,240000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1842000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1702000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1702000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1446000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10800000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9243000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9243000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1006000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-991000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-991000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q4,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6550000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21957000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21957000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,39000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,261000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13416000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9045000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9045000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13141000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15651000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2499000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2499000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1385000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,65000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1320000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1320000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10224000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3749000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3749000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,197000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,59000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13478000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10033000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10033000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-341000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17048000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15858000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15858000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-688000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59892000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,350000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59554000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59554000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,53729000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5922000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5922000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-52000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54547000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6380000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-48219000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-48219000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1467000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1445000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1445000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-55586000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2503000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2503000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15635000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8199000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7638000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7638000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10019000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,75000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,635000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-44000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1167000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5871000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5871000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10221000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11594000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1349000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1349000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,89000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,89000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,89000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4433000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4130000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4130000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-141000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14351000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31740000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17248000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17248000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,557000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,557000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,557000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13675000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,50053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,88000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,434000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-610000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14812000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,35112000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,35112000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-378000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61178000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34243000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27313000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27313000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,474000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,474000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,474000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8273000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5042000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5042000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,484000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,498000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-982000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4932000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4932000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-485000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12655000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22350000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9213000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9213000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,44000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4325000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,148000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,42009000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42009000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,129000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,471000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1235000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-46984000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5610000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5610000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-256000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8153000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15436000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7027000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7027000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2014000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2014000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2014000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3431000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,66000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,28753000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28753000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,141000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,561000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,69410000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,98861000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,98861000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-100000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-127679000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20466000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-172000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-107485000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-107485000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,245000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,245000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,245000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8379000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22000000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2418000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2418000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,165000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,619000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1237000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18642000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-400000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19751000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28325000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8174000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8174000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5907000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17500000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5812000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5812000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,204000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,593000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,602000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9586000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2375000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2375000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1580000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40721000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46390000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,9000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4098000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4098000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,159000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,159000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,159000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1882000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,506000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26189000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26189000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,339000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,562000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1836000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1067000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29993000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29993000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2197000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34622000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31187000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5632000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5632000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,162000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,146000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,146000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24507000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5707000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1645000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1645000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,433000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,448000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2264000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8554000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10054000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10054000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1513000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49939000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50995000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-457000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-457000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,547000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,530000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,530000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10127000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1076000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1076000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,434000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,294000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,821000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2585000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2112000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2112000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-613000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65929000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35115000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31427000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31427000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1985000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1968000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1968000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31571000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3405000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1802000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1802000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,455000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,207000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2173000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3159000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2126000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2126000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-415000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41939000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36207000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6147000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6147000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,79000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,61000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,61000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8212000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3500000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4980000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4980000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,493000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,188000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2956000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4488000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-953000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-73671000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75489000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,865000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,865000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,49000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4041000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1018000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5392000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5392000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,528000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,218000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2974000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1330000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3002000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3002000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-578000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77602000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,79986000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1806000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1806000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-193000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-211000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-211000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1407000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,552000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,158000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3136000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-216000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4796000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4796000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-741000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34949000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43348000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7658000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7658000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,208000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,190000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,190000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3052000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36508000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36508000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,564000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,138000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2722000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17374000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,57306000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,57306000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-234000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65149000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50482000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14901000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14901000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1079000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-53000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1007000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1007000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43412000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,561000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11693000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11693000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,587000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,88000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4078000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12037000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4409000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4409000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-504000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54710000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52766000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2448000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2448000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,436000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,417000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,417000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2378000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,13000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12555000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12555000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,613000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,22000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3264000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24032000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7578000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7578000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-752000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45011000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52220000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6457000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6457000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2207000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2193000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1127000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9870000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20288000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20288000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,657000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-348000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3971000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20520000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4048000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4048000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1102000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-79355000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48995000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31462000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31462000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2985000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2965000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2965000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24449000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11521000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27420000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27420000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,661000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-597000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4197000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3340000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28341000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28341000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-623000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-114027000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,106701000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7949000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7949000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1052000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1033000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1033000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21425000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4684000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26011000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26011000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,680000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-977000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5882000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1342000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,30254000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,30254000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-384000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119546000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,98999000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20931000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20931000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1161000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1140000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1140000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10463000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,802000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1236000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4704000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21671000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,30086000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,30086000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2507000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-152166000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,155995000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1322000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1322000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,278000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,257000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,257000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31665000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9950000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7036000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7036000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,885000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1276000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3891000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8003000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2533000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2533000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2230000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81670000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14847000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14847000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6139000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5627000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,490000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,490000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11824000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2660000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9191000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9191000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,891000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-847000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3283000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3973000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8545000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8545000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-296000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195930000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,144018000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-52208000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-52208000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,709000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,687000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,687000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-42976000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,57000.0
